Relief of hypersensitivity after nerve injury from systemic donepezil involves spinal cholinergic and γ-aminobutyric acid mechanisms

Anesthesiology

Volumn 118, Issue 1, 2013, Pages 173-180

  Kimura, Masafumi ^a   Hayashida, Ken Ichiro ^a   Eisenach, James C ^b   Saito, Shigeru ^a   Obata, Hideaki ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ATROPINE; BICUCULLINE; DONEPEZIL; MECAMYLAMINE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC ACTIVITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; MALE; MICRODIALYSIS; NERVE INJURY; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD DORSAL HORN;

ANIMALS; ATROPINE; BICUCULLINE; CHOLINERGIC AGENTS; CHOLINESTERASE INHIBITORS; DISEASE MODELS, ANIMAL; GABA AGENTS; GABA ANTAGONISTS; GABA-A RECEPTOR ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; INDANS; MALE; MECAMYLAMINE; NEURALGIA; NICOTINIC ANTAGONISTS; ORGANOPHOSPHORUS COMPOUNDS; PARASYMPATHOLYTICS; PERIPHERAL NERVE INJURIES; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; SPINAL NERVES;

EID: 84871613909     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e318277a81c     Document Type: Article

References (57)

1. O'Connor AB, Dworkin RH: Treatment of neuropathic pain: An overview of recent guidelines. Am J Med 2009; 122(10 Suppl):S22-32
2. Obata H, Saito S, Koizuka S, Nishikawa K, Goto F: The monoamine-mediated antiallodynic effects of intrathecally administered milnacipran, a serotonin noradrenaline reup-take inhibitor, in a rat model of neuropathic pain. Anesth Analg 2005; 100:1406-10 (Pubitemid 40577395)
3. Hayashida K, Parker R, Eisenach JC: Oral gabapentin acti-vates spinal cholinergic circuits to reduce hypersensitivity after peripheral nerve injury and interacts synergistically with oral donepezil. ANESTHESiLOGY 2007; 106:1213-9 (Pubitemid 46828175)
4. Weinstock M, Davidson JT, Rosin AJ, Schnieden H: Effect of physostigmine on morphine-induced postoperative pain and somnolence. Br J Anaesth 1982; 54:429-34 (Pubitemid 12143827)
5. Lauretti GR, Hood DD, Eisenach JC, Pfeifer BL: A multi-cen-ter study of intrathecal neostigmine for analgesia following vaginal hysterectomy ANESTHESiLOGY 1998; 89:913-8 (Pubitemid 28463297)
6. Hood DD, Mallak KA, Eisenach JC, Tong C: Interaction between intrathecal neostigmine and epidural clonidine in human volunteers. ANESTHESiLOGY 1996; 85:315-25 (Pubitemid 26265232)
7. Clayton BA, Hayashida K, Childers SR, Xiao R, Eisenach JC: Oral donepezil reduces hypersensitivity after nerve injury by a spinal muscarinic receptor mechanism. ANESTHESiLOGY 2007; 106:1019-25 (Pubitemid 46684070)
8. Pan HL, Chen SR, Eisenach JC: Intrathecal clonidine alleviates allodynia in neuropathic rats: Interaction with spinal muscarinic and nicotinic receptors. ANESTHESiLOGY 1999; 90:509-14 (Pubitemid 29071521)
9. Paqueron X, Li X, Bantel C, Tobin JR, Voytko ML, Eisenach JC: An obligatory role for spinal cholinergic neurons in the anti-allodynic effects of clonidine after peripheral nerve injury ANESTHESiLOGY 2001; 94:1074-81 (Pubitemid 32506137)
10. Eisenach JC, Detweiler DJ, Tong C, D'Angelo R, Hood DD: Cerebrospinal fuid norepinephrine and acetylcholine con-centrations during acute pain. Anesth Analg 1996; 82:621-6 (Pubitemid 26072972)
11. Bouaziz H, Tong C, Eisenach JC: Postoperative analgesia from intrathecal neostigmine in sheep. Anesth Analg 1995; 80:1140-4
12. Baba H, Kohno T, Okamoto M, Goldstein PA, Shimoji K, Yoshimura M: Muscarinic facilitation of GABA release in substantia gelatinosa of the rat spinal dorsal horn. J Physiol (Lond) 1998; 508 (Pt 1):83-93 (Pubitemid 28167572)
13. Li DP, Chen SR, Pan YZ, Levey AI, Pan HL: Role of presyn-aptic muscarinic and GABA(B) receptors in spinal glutamate release and cholinergic analgesia in rats. J Physiol (Lond) 2002; 543(Pt 3):807-18
14. Rashid MH, Ueda H: Neuropathy-specifc analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism. Brain Res 2002; 953:53-62 (Pubitemid 35217807)
15. Genzen JR, Mc Gehee DS: Nicotinic modulation of GABAergic synaptic transmission in the spinal cord dorsal horn. Brain Res 2005; 1031:229-37 (Pubitemid 40093075)
16. Zhang HM, Li DP, Chen SR, Pan HL: M2, M3, and M4 receptor subtypes contribute to muscarinic potentiation of GABAergic inputs to spinal dorsal horn neurons. J Pharmacol Exp Ther 2005; 313:697-704
17. Kim SH, Chung JM: An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992; 50:355-63
18. Randall LO, Selitto JJ: A method for measurement of analge-sic activity on infamed tissue. Arch Int Pharmacodyn Ther 1957; 111:409-19
19. Malan TP, Mata HP, Porreca F: Spinal GABA(A) and GABA(B) receptor pharmacology in a rat model of neuropathic pain. ANESTHESiLOGY 2002; 96:1161-7 (Pubitemid 34462578)
20. Sokal DM, Chapman V: Inhibitory effects of spinal baclofen on spinal dorsal horn neurones in infamed and neuropathic rats in vivo. Brain Res 2003; 987:67-75 (Pubitemid 37267888)
21. Obata H, Kimura M, Nakajima K, Tobe M, Nishikawa K, Saito S: Monoamine-dependent, opioid-independent anti-hypersensitivity effects of intrathecally administered mil-nacipran, a serotonin noradrenaline reuptake inhibitor, in a postoperative pain model in rats. J Pharmacol Exp Ther 2010; 334:1059-65
22. Fujimoto JM, Rady JJ: Intracerebroventricular physostig-mine-induced analgesia: Enhancement by naloxone, beta-funaltrexamine and nor-binaltorphimine and antagonism by dynorphin A (1-17). J Pharmacol Exp Ther 1989; 251:1045-52 (Pubitemid 20024923)
23. Yaksh TL, Dirksen R, Harty GJ: Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat. Eur J Pharmacol 1985; 117:81-8 (Pubitemid 16204502)
24. Dussor GO, Helesic G, Hargreaves KM, Flores CM: Cholinergic modulation of nociceptive responses in vivo and neuropep-tide release in vitro at the level of the primary sensory neu-ron. Pain 2004; 107:22-32 (Pubitemid 38058695)
25. Cordero-Erausquin M, Marubio LM, Klink R, Changeux JP: Nicotinic receptor function: New perspectives from knock-out mice. Trends Pharmacol Sci 2000; 21:211-7 (Pubitemid 30331090)
26. Vincler M: Neuronal nicotinic receptors as targets for novel analgesics. Expert Opin Investig Drugs 2005; 14:1191-8 (Pubitemid 41488868)
27. Young T, Wittenauer S, Parker R, Vincler M: Peripheral nerve injury alters spinal nicotinic acetylcholine receptor pharma-cology. Eur J Pharmacol 2008; 590:163-9
28. Naguib M, Yaksh TL: Antinociceptive effects of spinal cholin-esterase inhibition and isobolographic analysis of the inter-action with mu and alpha 2 receptor systems. ANESTHESiLOGY 1994; 80:1338-48 (Pubitemid 24182608)
29. Chiari A, Tobin JR, Pan HL, Hood DD, Eisenach JC: Sex dif-ferences in cholinergic analgesia I: A supplemental nico-tinic mechanism in normal females. ANESTHESiLOGY 1999; 91:1447-54 (Pubitemid 29506109)
30. Gomeza J, Shannon H, Kostenis E, Felder C, Zhang L, Brodkin J, Grinberg A, Sheng H, Wess J: Pronounced pharmacologic defcits in M2 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 1999; 96:1692-7 (Pubitemid 29098513)
31. Bernardini N, Reeh PW, Sauer SK: Muscarinic M2 receptors inhibit heat-induced CGRP release from isolated rat skin. Neuroreport 2001; 12:2457-60 (Pubitemid 32682202)
32. Hayashida KI, Bynum T, Vincler M, Eisenach JC: Inhibitory M2 muscarinic receptors are upregulated in both axotomized and intact small diameter dorsal root ganglion cells after peripheral nerve injury. Neuroscience 2006; 140:259-68 (Pubitemid 43668444)
33. Todd AJ: Immunohistochemical evidence that acetylcholine and glycine exist in different populations of GABAergic neu-rons in lamina III of rat spinal dorsal horn. Neuroscience 1991; 44:741-6
34. Mesnage B, Gaillard S, Godin AG, Rodeau JL, Hammer M, Von Engelhardt J, Wiseman PW, De Koninck Y, Schlichter R, Cordero-Erausquin M: Morphological and functional charac-terization of cholinergic interneurons in the dorsal horn of the mouse spinal cord. J Comp Neurol 2011; 519:3139-58
35. Chen SR, Pan HL: Spinal GABAB receptors mediate antinoci-ceptive actions of cholinergic agents in normal and diabetic rats. Brain Res 2003; 965:67-74
36. Takeda D, Nakatsuka T, Papke R, Gu JG: Modulation of inhib-itory synaptic activity by a non-alpha4beta2, non-alpha7 sub-type of nicotinic receptors in the substantia gelatinosa of adult rat spinal cord. Pain 2003; 101:13-23 (Pubitemid 36044650)
37. Castro-Lopes JM, Tavares I, Coimbra A: GABA decreases in the spinal cord dorsal horn after peripheral neurectomy Brain Res 1993; 620:287-91
38. Ibuki T, Hama AT, Wang XT, Pappas GD, Sagen J: Loss of GABA-immunoreactivity in the spinal dorsal horn of rats with peripheral nerve injury and promotion of recovery by adrenal medullary grafts. Neuroscience 1997; 76:845-58 (Pubitemid 27013423)
39. Eaton MJ, Plunkett JA, Karmally S, Martinez MA, Montanez K: Changes in GAD- and GABA- immunoreactivity in the spinal dorsal horn after peripheral nerve injury and promotion of recovery by lumbar transplant of immortalized serotonergic precursors. J Chem Neuroanat 1998; 16:57-72 (Pubitemid 29049099)
40. Moore KA, Kohno T, Karchewski LA, Scholz J, Baba H, Woolf CJ: Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superfcial dorsal horn of the spinal cord. J Neurosci 2002; 22:6724-31 (Pubitemid 35386428)
41. Yoshizumi M, Parker RA, Eisenach JC, Hayashida K: Gabapentin inhibits γ-amino butyric acid release in the locus coeruleus but not in the spinal dorsal horn after peripheral nerve injury in rats. ANESTHESiLOGY 2012; 116:1347-53
42. Scholz J, Broom DC, Youn DH, Mills CD, Kohno T, Suter MR, Moore KA, Decosterd I, Coggeshall RE, Woolf CJ: Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury. J Neurosci 2005; 25:7317-23 (Pubitemid 41129803)
43. Yowtak J, Lee KY, Kim HY, Wang J, Kim HK, Chung K, Chung JM: Reactive oxygen species contribute to neuropathic pain by reducing spinal GABA release. Pain 2011; 152:844-52
44. Polgár E, Hughes DI, Riddell JS, Maxwell DJ, Puskár Z, Todd AJ: Selective loss of spinal GABAergic or glycinergic neurons is not necessary for development of thermal hyperalgesia in the chronic constriction injury model of neuropathic pain. Pain 2003; 104:229-39 (Pubitemid 36835892)
45. Polgár E, Gray S, Riddell JS, Todd AJ: Lack of evidence for signifcant neuronal loss in laminae I-III of the spinal dorsal horn of the rat in the chronic constriction injury model. Pain 2004; 111:144-50 (Pubitemid 39141016)
46. Polgár E, Hughes DI, Arham AZ, Todd AJ: Loss of neurons from laminas I-III of the spinal dorsal horn is not required for development of tactile allodynia in the spared nerve injury model of neuropathic pain. J Neurosci 2005; 25:6658-66 (Pubitemid 40995298)
47. Polgár E, Todd AJ: Tactile allodynia can occur in the spared nerve injury model in the rat without selective loss of GABA or GABA(A) receptors from synapses in laminae I-II of the ipsilateral spinal dorsal horn. Neuroscience 2008; 156:193-202
48. Coull JA, Boudreau D, Bachand K, Prescott SA, Nault F, Sík A, De Koninck P, De Koninck Y: Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neu-ropathic pain. Nature 2003; 424:938-42 (Pubitemid 37051684)
49. Janssen SP, Truin M, Van Kleef M, Joosten EA: Differential GABAergic disinhibition during the development of painful peripheral neuropathy Neuroscience 2011; 184:183-94
50. Hwang JH, Yaksh TL: The effect of spinal GABA receptor agonists on tactile allodynia in a surgically-induced neuro-pathic pain model in the rat Pain 1997; 70:15-22 (Pubitemid 27128293)
51. Eaton MJ, Martinez MA, Karmally S: A single intrathecal injection of GABA permanently reverses neuropathic pain after nerve injury. Brain Res 1999; 835:334-9 (Pubitemid 29343798)
52. Jergova S, Hentall ID, Gajavelli S, Varghese MS, Sagen J: Intraspinal transplantation of GABAergic neural progeni-tors attenuates neuropathic pain in rats: A pharmacologic and neurophysiological evaluation. Exp Neurol 2012; 234:39-49
53. Slatkin NE, Rhiner M: Treatment of opiate-related sedation: utility of the cholinesterase inhibitors. J Support Oncol 2003; 1:53-63
54. Ogura H, Kosasa T, Kuriya Y, Yamanishi Y: Donepezil, a cen-trally acting acetylcholinesterase inhibitor, alleviates learning defcits in hypocholinergic models in rats. Methods Find Exp Clin Pharmacol 2000; 22:89-95 (Pubitemid 30304435)
55. Yamaguchi Y, Higashi M, Matsuno T, Kawashima S: Ameliorative effects of azaindolizinone derivative ZSET845 on scopolamine-induced defcits in passive avoidance and radial-arm maze learning in the rat. Jpn J Pharmacol 2001; 87:240-4
56. Hayashida K, Eisenach JC: Spinal α 2-adrenoceptor-mediated analgesia in neuropathic pain refects brain-derived nerve growth factor and changes in spinal cholinergic neuronal function. ANESTHESiLOGY 2010; 113:406-12
57. Hayashida K, Eisenach JC: Multiplicative interactions to enhance gabapentin to treat neuropathic pain. Eur J Pharmacol 2008; 598:21-6